These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 22014461)
1. The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro. Boanini E; Torricelli P; Gazzano M; Fini M; Bigi A Biomaterials; 2012 Jan; 33(2):722-30. PubMed ID: 22014461 [TBL] [Abstract][Full Text] [Related]
2. Combined effect of strontium and zoledronate on hydroxyapatite structure and bone cell responses. Boanini E; Torricelli P; Gazzano M; Della Bella E; Fini M; Bigi A Biomaterials; 2014 Jul; 35(21):5619-26. PubMed ID: 24731709 [TBL] [Abstract][Full Text] [Related]
3. Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells. Boanini E; Torricelli P; Gazzano M; Giardino R; Bigi A Biomaterials; 2008 Mar; 29(7):790-6. PubMed ID: 18022226 [TBL] [Abstract][Full Text] [Related]
4. The effect of alendronate doped calcium phosphates on bone cells activity. Boanini E; Torricelli P; Gazzano M; Fini M; Bigi A Bone; 2012 Nov; 51(5):944-52. PubMed ID: 22878156 [TBL] [Abstract][Full Text] [Related]
5. Biofunctional alendronate-Hydroxyapatite thin films deposited by Matrix Assisted Pulsed Laser Evaporation. Bigi A; Boanini E; Capuccini C; Fini M; Mihailescu IN; Ristoscu C; Sima F; Torricelli P Biomaterials; 2009 Oct; 30(31):6168-77. PubMed ID: 19692118 [TBL] [Abstract][Full Text] [Related]
6. Interaction of Sr-doped hydroxyapatite nanocrystals with osteoclast and osteoblast-like cells. Capuccini C; Torricelli P; Boanini E; Gazzano M; Giardino R; Bigi A J Biomed Mater Res A; 2009 Jun; 89(3):594-600. PubMed ID: 18437694 [TBL] [Abstract][Full Text] [Related]
7. Nanocomposites of hydroxyapatite with aspartic acid and glutamic acid and their interaction with osteoblast-like cells. Boanini E; Torricelli P; Gazzano M; Giardino R; Bigi A Biomaterials; 2006 Sep; 27(25):4428-33. PubMed ID: 16682075 [TBL] [Abstract][Full Text] [Related]
8. Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells. Panzavolta S; Torricelli P; Bracci B; Fini M; Bigi A J Inorg Biochem; 2009 Jan; 103(1):101-6. PubMed ID: 18977031 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of osteoblast function in vitro by aminobisphosphonates. Orriss IR; Key ML; Colston KW; Arnett TR J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973 [TBL] [Abstract][Full Text] [Related]
11. Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast-osteoclast-endothelial cell co-culture study. Forte L; Torricelli P; Boanini E; Gazzano M; Rubini K; Fini M; Bigi A Acta Biomater; 2016 Mar; 32():298-308. PubMed ID: 26689470 [TBL] [Abstract][Full Text] [Related]
12. Exposed hydroxyapatite particles on the surface of photo-crosslinked nanocomposites for promoting MC3T3 cell proliferation and differentiation. Cai L; Guinn AS; Wang S Acta Biomater; 2011 May; 7(5):2185-99. PubMed ID: 21284960 [TBL] [Abstract][Full Text] [Related]
13. Sr-containing hydroxyapatite: morphologies of HA crystals and bioactivity on osteoblast cells. Aina V; Bergandi L; Lusvardi G; Malavasi G; Imrie FE; Gibson IR; Cerrato G; Ghigo D Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1132-42. PubMed ID: 23827552 [TBL] [Abstract][Full Text] [Related]
14. The role of hydroxyapatite in citric acid-based nanocomposites: surface characteristics, degradation, and osteogenicity in vitro. Chung EJ; Sugimoto MJ; Ameer GA Acta Biomater; 2011 Nov; 7(11):4057-63. PubMed ID: 21784176 [TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells. Kaiser T; Teufel I; Geiger K; Vater Y; Aicher WK; Klein G; Fehm T Breast Cancer Res Treat; 2013 Jul; 140(1):35-48. PubMed ID: 23807419 [TBL] [Abstract][Full Text] [Related]
16. Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films. Hayden RS; Vollrath M; Kaplan DL Acta Biomater; 2014 Jan; 10(1):486-93. PubMed ID: 24096150 [TBL] [Abstract][Full Text] [Related]
17. The fabrication of nano-hydroxyapatite on PLGA and PLGA/collagen nanofibrous composite scaffolds and their effects in osteoblastic behavior for bone tissue engineering. Ngiam M; Liao S; Patil AJ; Cheng Z; Chan CK; Ramakrishna S Bone; 2009 Jul; 45(1):4-16. PubMed ID: 19358900 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of collagen-chitosan-hydroxyapatite nanocomposites for bone grafting. Wang X; Wang X; Tan Y; Zhang B; Gu Z; Li X J Biomed Mater Res A; 2009 Jun; 89(4):1079-87. PubMed ID: 18478560 [TBL] [Abstract][Full Text] [Related]
19. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679 [TBL] [Abstract][Full Text] [Related]
20. Short-term effects of zoledronate on the histomorphology of osteoclast in young albino rats. Ralte S; Khatri K; Nagar M Ann Anat; 2011 Dec; 193(6):509-15. PubMed ID: 21530208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]